Spronk, P.

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

Schauwvlieghe, A. F. A. D., Rijnders, B. J. A., Philips, N., Verwijs, R., Vanderbeke, L., Van Tienen, C., Lagrou, K., Verweij, P. E., Van de Veerdonk, F. L., Gommers, D., et al. (2018) · The Lancet Respiratory Medicine

Antifungal resistance and susceptibilityInfluenza Virus Research Studies

Cited by 886

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

Pachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G., Malbrain, M., Aoun, M., Garbino, J., et al. (2006) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 307

Prevention of relapses in systemic lupus erythematosus

Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 290

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation

Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 115

Clinical review: Strict or loose glycemic control in critically ill patients - implementing best available evidence from randomized controlled trials

Schultz, M. J., Harmsen, R. E., & Spronk, P. E. (2010) · Critical Care

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research

Cited by 53